Evaluation of intrauterine insemination practices: a 1 year prospective study in seven French assisted reproduction technology centers

Gonadotropin-releasing hormone antagonist used with multifollicular stimulation allows high delivery rates in intrauterine insemination.

0
0

Authors

Oriana Monraisin, M.D., Lucie Chansel-Debordeaux, M.D., Alexandra Chiron, M.D., Sébastien Floret, M.D., Steven Cens, M.D., Sylvain Bourrinet, M.D., Sophie Paulhac, M.D., Clément Jimenez, M.D., Ph.D., Jean Parinaud, M.D., Ph.D., Roger Leandri, M.D., Ph.D.

Volume 105, Issue 6, Pages 1589-1593

Abstract

Objective:

To determine the best practices of intrauterine insemination with the partner’s fresh sperm.

Design:

Prospective multicenter observational study.

Setting:

Assisted reproduction technology (ART) centers.

Patient(s):

Seven hundred and seven patients entering the program, regardless of age or cause of infertility.

Intervention(s):

Intrauterine insemination by standard procedures.

Main Outcome Measure(s):

Effect of patient characteristics (duration of infertility, indications, age, parity, body mass index, semen parameters) as well as IUI parameters on delivery rates per couple or per attempt.

Result(s):

The overall live birth rate was 11.4% per cycle, varying from 8.4% to 17.6% between centers. The main differences in practice that had a statistically significant impact on the delivery rate were the use of gonadotropin-releasing hormone (GnRH) antagonists (15.2% with versus 9.4% without) and the number of mature recruited follicles (9.4% for one versus 15.2% for two).

Conclusion(s):

Our results indicate that the use of GnRH antagonists has a positive effect on the delivery rate, especially in the multifollicular stimulations that are required when women are older than 27 years.

Read the full text at: http://www.fertstert.org/article/S0015-0282(16)00080-7/fulltext

Go to the profile of Fertility and Sterility

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. The journal publishes juried original scientific articles in clinical and laboratory research relevant to reproductive endocrinology, urology, andrology, physiology, immunology, genetics, contraception, and menopause. Fertility and Sterility® encourages and supports meaningful basic and clinical research, and facilitates and promotes excellence in professional education, in the field of reproductive medicine.

No comments yet.